Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

NCT02831361 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

290

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Gemigliptin
DRUG: Gemigliptin placebo
DRUG: Metformin
PROCEDURE: Diet/exercise questionnaire

Sponsor

LG Life Sciences